Cristhyne Leon
Head of Scientific Support Nova In Silico
Since joining Nova in 2021, Cristhyne has been pivotal in advancing Model-Informed Drug Development by pairing robust mechanistic models with AI to enhance clinical trial predictions. As Scientific Project Lead and Head of Scientific Support, she oversees project portfolio excellence, mentors project managers, and helps sponsors maximize in silico approaches across drug development. Active in the global pharmacometrics community, Cristhyne serves on the leadership teams for ISoP’s QSP Special Interest Group (QSP SIG) and is an active member of its Immunology & Inflammation Working Group.
Seminars
Wednesday 18th November 2026
Advancing Mechanistic Model-Informed Drug Development: From Biological Insights to AI Integration
10:00 am
- Landscape: The evolving role and impact of Quantitative Systems Pharmacology (QSP) and AI within Model-Informed Drug Development (MIDD).
- Transforming drug development through QSP modeling: Case studies from the GSK-Nova collaboration illustrating how QSP informs critical decisions across diverse therapeutic area and modalities
- Future Outlook: Challenges, opportunities, and key takeaways for integrating AI into biopharma QSP pipelines.
